ELP2
protein-codingelongator acetyltransferase complex subunit 2, the group of WD repeat domain containing|Elongator acetyltransferase complex
Gene summary
The protein encoded by this gene is a core subunit of the elongator complex, a histone acetyltransferase complex that associates with RNA polymerase II. In addition to histone acetylation, the encoded protein effects transcriptional elongation and may help remodel chromatin. [provided by RefSeq, May 2016]
- STATIP1
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~51.1 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0014996
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0100516
Submitter: ClinGen
*ELP2* was first reported in relation to autosomal recessive complex neurodevelopmental disorder with motor features in 2011 (Najmabadi et al., PMID: 21937992). Affected individuals demonstrate a range of phenotypic severity included but not limited to intellectual disability, developmental delay, and autism spectrum disorder, as well as motor features including spastic diplegia, choreoathetosis, and ataxia. Eight variants (missense, nonsense, frameshift, and splice site) that have been reported in 7 probands within 6 publications (PMIDs: 25847581, 28726809, 33393008, 33510603, 34653680, 33976153) are included in this curation. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. The mechanism of pathogenicity is reported to be loss of function (PMID:33976153). This gene-disease relationship is also supported by *in vitro* functional assays for commonly reported missense variants as well as two mouse models (PMID: 33976153). Affinity, enzymatic activity, and *in vitro* analyses of purified human and murine *ELP2* proteins show that commonly identified single amino acid substitutions impair the activity and function of the *ELP2* complex in tRNA modification during translation. Two mouse models, a homozygous p.His206Arg and compound heterozygous p.His206Arg/p.Arg462Gln, modified using CRISPR-Cas9 editing exhibited physical manifestations of developmental delay and severe motor defects including stereotypic behavior in the form of repetitive self grooming and abnormal hind-limb clasping, features commonly identified in ID/ASD mouse models. Neuroimaging of the homozygous p.His206Arg mice revealed loss of axonal tract integrity among major cortical white matter in the brain (PMID:33976153). Lastly, morphologic abnormalities were identified in the cortical neurons of the mutant mice and impairment of neurogenesis was seen by analysis of the brain tissue at the peak of neurogenesis (PMID:33976153). In summary, there is definitive evidence supporting the relationship between *ELP2* and autosomal recessive complex neurodevelopmental disorder with motor features. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Intellectual Disability/Autism GCEP on the meeting date June 23, 2025 (SOP Version 10).
Inheritance Pattern: AR
Disease ID:MONDO:0014996
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0014996
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0014996
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to ELP2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_018255.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 4 | 23 | 2 | 29 | ||
| missense | 2 | 4 | 148 | 15 | 2 | 171 |
| nonsense | 2 | 7 | 3 | 12 | ||
| start loss | 0 | |||||
| frameshift | 1 | 8 | 1 | 10 | ||
| splice donor/acceptor (+/-2bp) | 7 | 7 | ||||
| Total | 5 | 19 | 163 | 38 | 4 | 229 |
Highest pathogenic variant AF is 0.00006567656
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_060725.1 | 22 | MANE Select | |
| Ensembl | ENSP00000350967.6 | 22 | MANE Select | |
| RefSeq | NP_001229804.1 | 23 | Standard | |
| RefSeq | NP_001229805.1 | 21 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Chromatin modifying enzymes
- HATs acetylate histones
- Chromatin organization
Biological Process
- tRNA wobble uridine modification
- regulation of transcription by RNA polymerase II
- transcription elongation from RNA polymerase II promoter
- regulation of JAK-STAT cascade
Molecular Function
- RNA polymerase II complex binding
- protein kinase binding
Cellular Component
- cytoplasm
- cytosol
- transcription elongation factor complex
- Elongator holoenzyme complex
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000442325
- Coding exons
- 23
- Length
- 48503
- Individuals with no LoFs
- 125624
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 124
- Defined
- 125748
- p
- 0.000493
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.575 | 419 | 453 | 0.924 | 0.0000219 | 5824 |
| Missense (PolyPhen) | 102 | 132.13 | 0.77194 | 1709 | ||
| Synonymous | 0.0151 | 162 | 162 | 0.998 | 0.00000839 | 1668 |
| Loss of Function | 2.30 | 40 | 59.1 | 0.677 | 0.00000308 | 642 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.0012 | 0.0012 | notable |
| Latino/Admixed American | 0.00073 | 0.00072 | rare |
| Ashkenazi Jewish | 0.000099 | 0.000099 | rare |
| East Asian | 0.00017 | 0.00016 | rare |
| Finnish | 0.000046 | 0.000046 | rare |
| European (Non-Finnish) | 0.00051 | 0.00051 | rare |
| South Asian | 0.00052 | 0.00052 | rare |
| Other | 0.00016 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Regulates the ligand-dependent activation of STAT3. {ECO:0000250}.;
- Disease
- DISEASE: Mental retardation, autosomal recessive 58 (MRT58) [MIM:617270]: A form of mental retardation, a disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRT58 transmission pattern is consistent with autosomal recessive inheritance. {ECO:0000269|PubMed:25847581}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.145
Intolerance Scores
- LoFtool
- 0.867
- RVIS EVS
- 1.21
- RVIS percentile EVS
- 93.02
Essentials
- Essential (CRISPR)
- E
- Essential (CRISPR2)
- E
- Essential (gene trap)
- E
- Indispensability pred.
- E
- Indispensability score
- 0.778
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | High | Medium | High |
| Cancer | High | High | High |